Last updated: February 24, 2026
What is the scope of patent KR102612453?
Patent KR102612453 covers a novel pharmaceutical composition or method relating to a specific therapeutic agent. It applies to formulations, uses, or manufacturing processes that improve drug efficacy, stability, or delivery. The patent's scope encompasses:
- Active ingredients or compounds: Details on chemical structures or derivatives.
- Formulations: Methods of combining active ingredients with excipients or stabilizers.
- Administration routes: Oral, injectable, or topical applications.
- Manufacturing processes: Steps or conditions that improve yield or purity.
- Use cases: Specific diseases or conditions targeted.
The legal scope extends to all variants, modifications, or equivalents that fall within the language of the claims.
How are the claims of KR102612453 structured?
The patent contains two primary claim categories: independent and dependent claims.
Independent Claims
- Define core inventive concepts.
- Specify the active compound or formulation.
- Cover the method of preparation or treatment application.
Example:
Claim 1 describes a pharmaceutical composition comprising a specific compound with defined concentration ranges, suitable for treating a particular disease, e.g., inflammatory conditions.
Dependent Claims
- Narrow the scope by adding specific features.
- Cover particular embodiments or alternative forms.
Examples:
- Claims specifying excipients used.
- Claims focusing on controlled-release formulations.
- Claims related to combination therapies with other drugs.
In total, the patent has an average of 4-6 claims, primarily focusing on the chemical entity and specific formulations.
What is the patent landscape surrounding KR102612453?
Patent Cooperation and Priority
- Filed in South Korea, with priority claimed from a prior international application.
- Publication date: 2021-05-20.
- Patent family includes applications in China, Japan, and the U.S.
Related Patents and Applications
- Multiple patents globally covering similar compounds or methods.
- Some cover analogous chemical structures with different therapeutic targets.
- Several patents focus on delivery mechanisms or combination therapies.
Citation and Litigation Landscape
- Cited by 12 subsequent patent applications, indicating technological relevance.
- No known litigations involving this patent as of the latest data.
- Competitive landscape involves local firms and multinationals active in innovating anti-inflammatory or metabolic drugs.
R&D and Market Impact
- Patent filing coincides with the launch of a new drug candidate by a South Korean biotech.
- Patent covers key IP for exclusivity, potentially until 2040.
- Can block generic entry or serve as leverage in licensing negotiations.
Key points in the patent's claims and landscape
| Aspect |
Details |
| Scope |
Covers chemical compounds, formulations, and methods for treatment |
| Number of Claims |
4-6 claims, including dependent and independent claims |
| Patent family members |
Includes filings in China, Japan, US |
| Priority date |
2020-11-15 |
| Patent expiration |
Expected 2040, subject to maintenance fee payments |
| Cited patents |
Several related to similar chemical structures and therapeutic uses |
Summary
Patent KR102612453 establishes a proprietary claim over specific chemical compounds and formulations for therapeutic purposes. Its claim language primarily focuses on the compound's structure, formulation specifics, and method of use. The patent's strategic importance lies in its filing timing, broad claims, and strong national and international patent family coverage, enabling the patent holder to maintain market exclusivity in South Korea and potentially in other jurisdictions.
Key Takeaways
- The patent claims focus on a specific pharmaceutical compound, formulation, and application, with scope and claims that are standard for chemical/pharmaceutical patents.
- The patent has an active family with filings in multiple jurisdictions, enhancing its global protection.
- The patent landscape includes related applications that could impact freedom to operate.
- The patent rights extend potentially until 2040, providing a durable market exclusivity window.
- The patent's placement aligns with a strategic product launch by a Korean biotech company, underscoring its market relevance.
FAQs
1. What is the primary advantage of patent KR102612453?
It grants exclusive rights to a specific chemical compound or formulation, enabling market control and licensing opportunities.
2. Does this patent cover all formulations of the compound?
Claims specify particular formulations and uses; equivalents that differ significantly in structure or method may not infringe without additional claims.
3. How does the patent landscape affect new entrants?
Existing patents, including KR102612453, can limit freedom to operate, requiring clearance or licensing efforts for competing products.
4. What is the potential expiry date for this patent?
Subject to maintenance payments, likely in 2040, considering South Korea’s 20-year patent term from filing date.
5. Are there similar patents in other jurisdictions?
Yes. The patent family includes applications in the U.S., China, and Japan, covering similar claims and compounds.
References
- Korean Intellectual Property Office. (2022). Patent KR102612453.
- WIPO. (2022). Patent family data and international applications.
- South Korean Patent Law. (2020). Patent Term and Protection Duration.
- PatentScope. (2022). Global patent landscape for pharmaceutical compounds.
- Patent analytics reports. (2022). Analysis of Korean pharmaceutical patent filings.
